Opinion|Videos|May 3, 2024

Best Practices for ESR1 Mutation Testing in Patients With Breast Cancer

An expert on breast cancer reviews currently available tests for ESR1 mutations and provides clinical insights on best practices for testing.


Related to this article

CAR T-cell therapy | Image: AdobeStock
In the years since the first approval for CAR T-cell therapy, major managed care plans have adopted mechanisms to include these treatments. But many employer-sponsored plans may not be required to cover them, and such treatments are "lasered out."